Evidence map›Paper›PMID 28769788›Full record

ArticleFrontiers in pharmacology2017

Association between

Anick Bérard, Andrea Gaedigk, Odile Sheehy, Christina Chambers, Mark Roth, Pina Bozzo, Diana Johnson, Kelly Kao, Sharon Lavigne, Lori Wolfe and 4 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. The dynamic serotonin system of the maternal brain.Archives of women's mental health · 2019
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anick BérardFaculty of Pharmacy, University of MontrealMontreal, QC, Canada.
Andrea GaedigkDivision of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy-Kansas CityKansas City, MO, United States.
Odile SheehyResearch Center, CHU Sainte-JustineMontreal, QC, Canada.
Christina ChambersDepartment of Pediatrics, University of California San DiegoLa Jolla, CA, United States.
Mark RothPregnancy Risk Network, NYS Teratogen Information ServiceBinghamton, NY, United States.
Pina BozzoMotherisk Program, Hospital for Sick ChildrenToronto, ON, Canada.
Diana JohnsonCalifornia Teratogen Information ServiceSan Diego, CA, United States.
Kelly KaoCalifornia Teratogen Information ServiceSan Diego, CA, United States.
Sharon LavigneConnecticut Pregnancy Exposure Information Service, Division of Human Genetics, University of Connecticut Health CenterFarmington, CT, United States.
Lori WolfeTexas Teratogen Information Service, University of North TexasDenton, TX, United States.
Dee QuinnArizona Pregnancy Riskline, Colleges of Medicine and Pharmacy, University of ArizonaTucson, AZ, United States.
Kristen DieterIllinois Teratology Information ServiceChicago, IL, United States.
Jin-Ping ZhaoResearch Center, CHU Sainte-JustineMontreal, QC, Canada.
OTIS (MotherToBaby) Collaborative Research Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antidepressant discontinuationCYP2D6 genotypesdosage modificationmaternal depression in pregnancy

Identifiers

PMID28769788
PMCPMC5511844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.